Abstract
In the last decade, radiofrequency ablation in combination with endoscopic mucosal resection has simplified and improved the treatment of Barrett's esophagus. These treatments not only reduced the progression of dysplastic Barrett's esophagus to esophageal adenocarcinoma but also decreased treatment-related complications. More recent data from larger series with extended follow-up periods are emerging to refine expectations in patients treated with radiofrequency ablation. Although most patients achieve eradication of neoplasia and intestinal metaplasia, in the long-term a substantial portion of patients develop recurrent disease. This article provides an updated review of radiofrequency ablation efficacy, complications, and durability.
Original language | English (US) |
---|---|
Pages (from-to) | 491-501 |
Number of pages | 11 |
Journal | Gastrointestinal Endoscopy Clinics of North America |
Volume | 27 |
Issue number | 3 |
DOIs | |
State | Published - Jul 2017 |
Keywords
- Barrett's esophagus
- Dysplasia
- Esophageal adenocarcinoma
- Neoplasia
- Radiofrequency ablation
ASJC Scopus subject areas
- Gastroenterology